What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?
Petrini P. Petrini P.
. Cell. 2021 Sep 16;184(19):4981-4995.e14. doi: 10.1016/j.cell.2021.08.004. Epub 2021 Aug 30. Cell. 2021. PMID: 34464586